LEXINGTON, Mass. - Voyager Therapeutics, Inc. (NASDAQ:VYGR), a biotechnology firm focused on neurogenetic medicines with a market capitalization of $290 million, announced today it is reassessing its ...

Bitcoin is holding above $95,000 despite heavy selling pressure, briefly dipping to $94,726 on Feb. 9 before recovering.

The PSAP Voyager hydrophones are self-contained, as they use the temperature difference in the surrounding water to power ...

Shares of Voyager Therapeutics, Inc. (NASDAQ:VYGR – Get Free Report) have been given an average recommendation of “Buy” by the nine brokerages that are covering the stock, MarketBeat.com reports.

FTX creditors and investors had accused the company's lawyers at Sullivan & Cromwell of failing to stop the fraud while positioning themselves for a lucrative position as the company's primary ...

In an unimaginable display of precision, RAF top gun pilots refuel their jets mid-air as the battle for air supremacy takes a ...

A total of 1079 guests have reviewed Voyager of the Seas, giving it a rating of 4.1 on a scale of 1-5. This was the second worst cruise that I have taken. The ship is outdated, with limited ...

ResMed’s strong demand for AirSense 11 boosts its earnings outlook. Learn why RMD stock is undervalued with growth ...

Atlas Ocean Voyages continues to experience strong demand, with record-setting charter sales for 2025 and beyond. This ongoing interest underscores the strength of the brand's luxury yacht expedition ...